John “Jack” Cahill is out to illuminate previously unseen processes with new technology, advancing our understanding of how chemicals interact to influence complex systems whether it’s in the human body or in the world beneath our feet.
Matthew Craig grew up eagerly exploring the forest patches and knee-high waterfalls just beyond his backyard in central Illinois’ corn belt. Today, that natural curiosity and the expertise he’s cultivated in biogeochemistry and ecology are focused on how carbon cycles in and out of soils, a process that can have tremendous impact on the Earth’s climate.
Scientists at ORNL used neutron scattering to determine whether a specific material’s atomic structure could host a novel state of matter called a spiral spin liquid.
Science has taken Melanie Mayes from Tennessee to the tropics, studying some of the most important ecosystems in the world.
To solve a long-standing puzzle about how long a neutron can “live” outside an atomic nucleus, physicists entertained a wild but testable theory positing the existence of a right-handed version of our left-handed universe.
Technology developed at ORNL to monitor plant productivity and health at wide scales has been licensed to Logan, Utah-based instrumentation firm Campbell Scientific Inc.
From helping 750 million viewers watch Princess Diana’s wedding to enabling individual neutron scientists observe subatomic events, Graeme Murdoch has helped engineer some of the world’s grandest sights and most exciting scientific discoveries.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.